药店板块短线走低，漱玉平民跌超6%，第一医药、大参林、一心堂、健之佳等跟跌。 ...

Investment Rating - The report maintains a "Neutral" rating for the pharmaceutical and biotechnology industry [1][42]. Core Insights - There is a recovery in demand for clinical research organizations (CROs), while the supply of experimental monkeys is tight, leading to price increases. The domestic financing for innovative drugs is gradually recovering, with a total financing amount of $4.086 billion from January to November 2025, representing a year-on-year increase of 10.6% [1][10]. - The pharmaceutical sector has underperformed compared to the CSI 300 index, with a year-to-date return of 14.49% against the CSI 300's 16.09% [22]. - The current valuation of the pharmaceutical sector is 33.0 times PE based on 2026 profit forecasts, which is a 41% premium over the overall A-share market (excluding financials) [23]. Summary by Sections Recent Trends - The CSI 300 index fell by 0.28% this week, while the pharmaceutical sector decreased by 0.14%, ranking 22nd among 31 primary sub-industries. The weekly performance of sub-sectors includes declines in chemical pharmaceuticals and biological products, while medical services and medical commerce showed gains [9][22]. Market Dynamics - The demand for CROs is recovering, and the supply of experimental monkeys is limited, with prices for 3-5 year old monkeys reaching 140,000 yuan each. This indicates a recovery in the domestic innovative drug research and development environment [10][11]. Valuation - The pharmaceutical sector's current valuation is 29.1 times PE based on trailing twelve months (TTM) earnings, which is below the historical average of 35.0 times PE. The sector has a 17.2% premium over the overall A-share market [23]. Company Performance - Notable performers in the pharmaceutical commercial sector this week include Huaren Health, Luyuan Pharmaceutical, and Shuyuan Pingmin, with significant weekly gains [25]. Key Company Meetings - Upcoming shareholder meetings include Dong'e Ejiao, Zhonghe Holdings, and Yiling Pharmaceutical on December 22, among others [31][32][33].

格隆汇12月19日丨漱玉平民(301017.SZ)公布，截至2025年12月18日，公司已通过集中竞价交易方式累 计出售回购股份2,988,788股，占公司总股本比例为0.7373%，出售所得资金总额为47,011,303.16元（不 含交易费用），成交最高价为16.77元/股，成交最低价为15.00元/股，成交均价为15.73元/股。 ...

格隆汇12月19日丨漱玉平民(301017.SZ)公布，截至2025年12月18日，公司已通过集中竞价交易方式累 计出售回购股份2,988,788股，占公司总股本比例为0.7373%，出售所得资金总额为47,011,303.16元（不 含交易费用），成交最高价为16.77元/股，成交最低价为15.00元/股，成交均价为15.73元/股。 ...

截至本公告日，本次出售计划已实施完毕。根据《深圳证券交易所上市公司自律监管 指引第 9 号——回购股份》等相关规定，上市公司采用集中竞价交易方式出售回购股份的， 出售计划实施完毕后，在两个交易日内披露出售结果暨股份变动公告。现将有关情况公告 如下： 一、公司已回购股份基本情况 | 证券代码：301017 | 证券简称：漱玉平民 | 公告编号：2025-114 | | --- | --- | --- | | 债券代码：123172 | 债券简称：漱玉转债 | | 漱玉平民大药房连锁股份有限公司 关于已回购股份出售结果暨股份变动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 漱玉平民大药房连锁股份有限公司（以下简称"公司"）于 2025 年 11 月 18 日召开第 四届董事会第十三次会议审议通过了《关于出售 2024 年已回购股份的议案》，根据公司于 2024 年 2 月 22 日披露的《回购报告书》之用途约定，同意公司以集中竞价方式出售已回购 股份,实施期限为自该公告披露之日起 15 个交易日后的 6 个月内（即 2025 年 12 月 10 日至 ...

Market Overview - The A-share market experienced slight fluctuations today, with large-cap blue-chip stocks showing strength, as the Shanghai Composite Index and the Shanghai 50 Index slightly rose, while technology growth stocks faced adjustments, leading to small declines in the ChiNext Index, Sci-Tech 50, and North China 50. The market turnover reached 1.68 trillion yuan [1]. Index Performance - The Shenzhen Component Index closed at 13,053.97, down by 1.29% - The Shanghai Composite Index closed at 3,876.37, up by 0.16% - The ChiNext Index closed at 3,107.06, down by 2.17% - The Sci-Tech 50 Index closed at 1,305.97, down by 1.46% - The North China 50 Index closed at 1,431.71, down by 0.51% [2]. Sector Performance - Active sectors included pharmaceutical commerce, high-dividend stocks, elderly care concepts, and commercial aerospace, while sectors such as Hainan, consumer electronics, glass fiber, and power grid equipment saw the largest declines [2]. - Defense and military industry attracted over 9.5 billion yuan in net inflows, while banking received over 5.5 billion yuan. Other sectors like automotive and biopharmaceuticals also saw significant inflows exceeding 4 billion yuan [3]. Investment Insights - Huazhang Securities noted that historically, years of significant gains see increased volatility in January of the following year, suggesting a potential adjustment phase ahead. Investors are advised to remain patient and await clearer signals for upward trends. The AI industry is highlighted as a stable long-term investment focus [3]. - Guotai Junan emphasized that the spring market typically starts between December and April, with potential early initiation if prior market adjustments and favorable policy expectations align. Current market conditions present a crucial window for positioning in the spring rally [3]. High Dividend Stocks - High-dividend stocks saw a strong performance in the afternoon, with all bank stocks rising. Notable gainers included Shanghai Bank and Chongqing Rural Commercial Bank [4]. - The demand for stable cash flows from long-term funds like insurance and pension funds has increased significantly in a low-interest-rate environment. Insurance companies are projected to increase equity allocations by over 410 billion yuan in the first three quarters of 2025, with high-dividend assets comprising over half of the new positions [4]. Elderly Care Sector - The elderly care concept stocks were notably active, with companies like Jiayou Meikang and Waineng Health hitting their daily limit up of 20% [4]. - The National Health Commission has issued a plan to enhance elderly care services, aiming for a more comprehensive system by 2027 [5]. Silver Economy - The silver economy market in China is projected to reach 8.3 trillion yuan by 2024 and exceed 20 trillion yuan by 2030, with the consumption potential of the elderly population expected to grow to 106 trillion yuan by 2050, positioning China as a leader in the global silver economy market [6]. - CITIC Securities forecasts that the number of new pension recipients will increase by approximately 5.5 to 6 million annually over the next 2-3 years, which will be a significant driver for the silver economy and domestic demand expansion [6].

资金流向方面，高换手率个股中，有18股今日获主力资金净流入，净流入金额较多的有海峡创新、天银 机电、西测测试，净流入金额分别为4.89亿元、4.05亿元、2.28亿元，净流出金额较多的有海科新源、 联特科技、波长光电，净流出金额分别为1.48亿元、1.46亿元、1.44亿元。（数据宝） 创业板指今日下跌2.17%，报收3107.06点，创业板全日成交额4498.55亿元，比上个交易日减少452.59亿 元。今日可交易创业板股中，730只股收盘上涨，涨幅超过10%的有10只，其中，德艺文创、漱玉平 民、万隆光电等4股涨停，涨幅在5%至10%之间的有34只，收盘下跌的有618只，跌幅超10%的有1只。 证券时报·数据宝统计显示，换手率方面，创业板今日平均换手率为3.27%，换手率区间分布显示，换手 率超过20%的有24只，换手率10%~20%之间的有78只，换手率5%~10%的有207只，换手率1%~5%的有 923只，换手率不足1%的有158只。 换手率最高的是德艺文创，该股今日收盘涨停，全天换手率39.21%，成交额7.28亿元；其次是天银机 电，该股今日收盘上涨16.53%，全天换手率38.66%，成交额4 ...

Market Overview - A total of 61 stocks hit the daily limit up, while 19 stocks faced limit down, resulting in a sealing rate of 76% [1] - The Shanghai Composite Index rose by 0.16%, while the Shenzhen Component Index and the ChiNext Index fell by 1.29% and 2.17% respectively [1] - The total trading volume in the Shanghai and Shenzhen markets was 1.66 trillion, a decrease of 155.7 billion from the previous trading day [1] Stock Performance - Baida Group achieved a six-day limit up streak, while Shengtong Energy and Pinao recorded five and four consecutive limit ups respectively [1][3] - The number of stocks advancing was nearly 2900, with notable performances in the pharmaceutical, banking, and retail sectors [1] - The commercial aerospace concept saw a resurgence, with stocks like Shunhao and Xibu Materials hitting limit up after previous declines [3][5] Sector Analysis - The pharmaceutical commercial sector experienced significant growth due to increased orders amid a rise in respiratory diseases during the winter season [14][15] - The retail sector, particularly driven by the "reward economy," showed strong performance with stocks like Baida Group and Nanjing Shanglv achieving consecutive limit ups [6][12] - The AI healthcare sector remained active, with Ant Group's AI health app "Antifortune" gaining popularity, leading to limit ups for companies like Meian Health and Huaren Health [7][19] Investment Themes - The commercial aerospace sector is highlighted as a strategic emerging industry, with government support and recent rocket launches boosting investor sentiment [5] - The "reward economy" is emerging as a new consumption model among younger demographics, contributing to the growth of related sectors [6][12] - The IP economy is gaining traction, with government initiatives aimed at promoting new consumption models and financial support for innovative businesses [16] Future Outlook - The market is expected to continue experiencing volatility, with a focus on small-cap stocks and growth sectors as larger stocks face profit-taking [9] - The Shanghai Composite Index is attempting to recover above key moving averages, indicating potential for further upward movement if trading volume increases [9]

资金流向方面，今日该股主力资金净流入9094.36万元，其中，特大单净流入9842.86万元，大单资金净 流出748.49万元。近5日主力资金净流入9910.32万元。（数据宝） 漱玉平民今日涨停，全天换手率20.04%，成交额8.09亿元，振幅17.91%。龙虎榜数据显示，机构净卖出 2949.92万元，深股通净买入119.19万元，营业部席位合计净买入2597.67万元。 深交所公开信息显示，当日该股因日收盘价涨幅达20.00%上榜，机构专用席位净卖出2949.92万元，深 股通净买入119.19万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交2.46亿元，其中，买入成交额为1.22亿 元，卖出成交额为1.24亿元，合计净卖出233.07万元。 具体来看，今日上榜的营业部中，共有3家机构专用席位现身，即卖三、卖四、卖五，合计买入金额 2758.71万元，卖出金额5708.64万元，合计净卖出2949.92万元，深股通为第一大买入营业部及第一大卖 出营业部，买入金额为4047.42万元，卖出金额为3930.23万元，合计净买入119.19万元。 | 买/ | 会员营业部名称 | 买入金额（万 ...

证券之星消息，12月18日医药商业板块较上一交易日上涨3.9%，漱玉平民领涨。当日上证指数报收于 3876.37，上涨0.16%。深证成指报收于13053.98，下跌1.29%。医药商业板块个股涨跌见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 从资金流向上来看，当日医药商业板块主力资金净流入8.88亿元，游资资金净流出3.41亿元，散户资金 净流出5.48亿元。医药商业板块个股资金流向见下表： ...